Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis

Area of Science:

• Medicinal Chemistry
• Parasitology
• Immunology

Background:

• Lipophilic bisphosphonates are investigated for therapeutic potential.
• Malaria parasites possess a geranylgeranyl diphosphate synthase (GGPPS) essential for survival.
• Human γδ T cells can be activated via farnesyl diphosphate synthase (FPPS).

Purpose of the Study:

• To synthesize and evaluate lipophilic bisphosphonates for anti-malarial activity.
• To assess the potential of these compounds in activating human γδ T cells.
• To identify structure-activity relationships for optimal efficacy.

Main Methods:

• Synthesis of 30 lipophilic bisphosphonates.
• In vitro testing against Plasmodium GGPPS and human FPPS.
• Cell-based assays to evaluate membrane permeability and activity.
• X-ray crystallography of a bisphosphonate bound to FPPS.

Main Results:

• Bisphosphonates showed activity against both Plasmodium GGPPS and human FPPS.
• Optimal enzyme inhibition and cell penetration were achieved with ~C10 side-chains.
• Shorter chains had poor cell permeability; longer chains were weak enzyme inhibitors.
• Crystal structure revealed potent inhibitor binding to FPPS.

Conclusions:

• Lipophilic bisphosphonates with ~C10 side-chains exhibit dual activity against malaria parasites and human FPPS.
• These compounds hold promise for a single-agent combined chemo-immunotherapeutic strategy against malaria.
• The findings open avenues for novel anti-malarial drug development.